Staar Surgical Reaches New 52-Week High (STAA)

NEW YORK (TheStreet) -- Staar Surgical (Nasdaq:STAA) hit a new 52-week high Tuesday as it is currently trading at $11.24, above its previous 52-week high of $11.19 with 100,073 shares traded as of 12:28 p.m. ET. Average volume has been 356,500 shares over the past 30 days.

Staar Surgical has a market cap of $398.5 million and is part of the health care sector and health services industry. Shares are up 81% year to date as of the close of trading on Monday.

STAAR Surgical Company, together with its subsidiaries, engages in the design, development, manufacture, and sale of implantable lenses for the cataracts and refractive surgery.

• Sign up for TheStreet's FREE Dividend and Income Investor Newsletter

TheStreet Ratings rates Staar Surgical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Staar Surgical Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

 

For more information on Staar Surgical click any of the following:

• Staar Surgical Stock Price

• Staar Surgical Analyst Ratings

• Staar Surgical Key Stats & Profile

• Staar Surgical Earnings

• Staar Surgical Ratio Comparison

• Staar Surgical Growth Rates

• Staar Surgical Balance Sheet

• Staar Surgical Cash Flow

• Staar Surgical Income Statement